Products/Services Company specialized in lentiviral vectors (LV) with two areas of expertise: 1. GMP CDMO: manufacture of LV from early stages to GMP. 2. Innovation: focused on providing a response to the main hurdles that currently exist within the gene therapy field: a. The need for cost-effective processes: •Developmentofimprovedproducercelllines. •Newpseudo-typingstrategies. b The enhancement of the safety profile: •Ownworldwidelicensednon-integrativeepisomal stable LV (LENTISOMA).
Dr. Natalia Elizalde email@example.com mobile +34 683 619 708